Literature DB >> 20142183

Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT).

Irene M Lang1, Sandra A Forman, Aldo P Maggioni, Witold Ruzyllo, Jean Renkin, Carlos Vozzi, P Gabriel Steg, Jose-Maria Hernandez-Garcia, Krzysztof Zmudka, Manuel Jimenez-Navarro, George Sopko, Gervasio A Lamas, Judith S Hochman.   

Abstract

AIMS: OAT randomised patients with an occluded infarct artery three to 28 days after myocardial infarction (MI). The study demonstrated that PCI did not reduce the occurrence of the primary composite endpoint of death, re-MI, and New York Heart Association class IV heart failure in comparison with patients assigned to optimal medical therapy alone (MED). In view of prior literature in similar cohorts showing fewer sudden cardiac deaths and less left ventricular (LV) remodelling, but excess re-MI with PCI, causes of death were analysed in more detail. METHODS AND
RESULTS: Stepwise Cox regression was used to examine baseline variables associated with causes of death. The immediate and primary cause of death did not differ between 1,101 PCI and 1,100 MED patients. One-year cardiovascular death rates were 3.8% for the PCI group, and 3.7% for the MED group, and 0.9% per year for the next four years in both groups. Five of six cases of cardiac rupture occurred in patients undergoing PCI.
CONCLUSIONS: In stable post-MI patients with occlusion of the infarct-related artery, PCI did not change the rate or cause of death. The observation that the majority of cardiac ruptures occurred in patients undergoing PCI deserves further investigation.

Entities:  

Mesh:

Year:  2009        PMID: 20142183      PMCID: PMC2893563          DOI: 10.4244/eijv5i5a98

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  37 in total

Review 1.  The late open artery hypothesis--a decade later.

Authors:  S Sadanandan; C Buller; V Menon; V Dzavik; M Terrin; B Thompson; G Lamas; J S Hochman
Journal:  Am Heart J       Date:  2001-09       Impact factor: 4.749

Review 2.  Ventricular septal rupture after acute myocardial infarction.

Authors:  Yochai Birnbaum; Michael C Fishbein; Carlos Blanche; Robert J Siegel
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

3.  Effect of successful late reperfusion by primary coronary angioplasty on mechanical complications of acute myocardial infarction.

Authors:  Daisaku Nakatani; Hiroshi Sato; Kunihiro Kinjo; Hiroya Mizuno; Eiji Hishida; Atsushi Hirayama; Masayoshi Mishima; Hiroshi Ito; Yasushi Matsumura; Masatsugu Hori
Journal:  Am J Cardiol       Date:  2003-10-01       Impact factor: 2.778

4.  Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study).

Authors:  Zaheer R Yousef; Simon R Redwood; Clifford A Bucknall; Alfred N Sulke; Michael S Marber
Journal:  J Am Coll Cardiol       Date:  2002-09-04       Impact factor: 24.094

5.  Survival and cause of death after myocardial infarction: the Danish MONICA study.

Authors:  H Brønnum-Hansen; T Jørgensen; M Davidsen; M Madsen; M Osler; L U Gerdes; M Schroll
Journal:  J Clin Epidemiol       Date:  2001-12       Impact factor: 6.437

6.  Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.

Authors:  F Zijlstra; J C Hoorntje; M J de Boer; S Reiffers; K Miedema; J P Ottervanger; A W van 't Hof; H Suryapranata
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

7.  Frequency of left ventricular free-wall rupture in patients with acute myocardial infarction treated with primary angioplasty.

Authors:  R Moreno; E López de Sá; J L López-Sendón; E García; J Soriano; M Abeytua; J Elízaga; J Botas; R Rubio; M Moreno; M A García-Fernández; J L Delcán
Journal:  Am J Cardiol       Date:  2000-03-15       Impact factor: 2.778

8.  Effectiveness of primary percutaneous coronary intervention for acute ST-elevation myocardial infarction from a 5-year single-center experience.

Authors:  Spela Tadel-Kocjancic; Simona Zorman; Anja Jazbec; Vojka Gorjup; Darko Zorman; Marko Noc
Journal:  Am J Cardiol       Date:  2007-12-11       Impact factor: 2.778

9.  Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006.

Authors:  C Michael Gibson; Yuri B Pride; Paul D Frederick; Charles V Pollack; John G Canto; Alan J Tiefenbrunn; W Douglas Weaver; Costas T Lambrew; William J French; Eric D Peterson; William J Rogers
Journal:  Am Heart J       Date:  2008-11-01       Impact factor: 4.749

10.  Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study.

Authors:  Mariusz Kruk; Jacek Kadziela; Harmony R Reynolds; Sandra A Forman; Zygmunt Sadowski; Bruce A Barton; Daniel B Mark; Aldo P Maggioni; Jonathan Leor; John G Webb; Michael Kapeliovich; Jose A Marin-Neto; Harvey D White; Gervasio A Lamas; Judith S Hochman
Journal:  JACC Cardiovasc Interv       Date:  2008-10       Impact factor: 11.195

View more
  1 in total

Review 1.  Association of Helicobacter pylori infection with coronary artery disease: is it an independent risk factor?

Authors:  Mohamed Riad
Journal:  Egypt Heart J       Date:  2021-07-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.